ENTITY
Betta Pharmaceuticals

Betta Pharmaceuticals (300558 CH)

48
Analysis
Health CareChina
Betta Pharmaceuticals Co., Ltd operates as a pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of malignant tumors, diabetes, cardiovascular, cerebrovascular, and other related diseases. Betta Pharmaceuticals markets throughout China.
more
Refresh
bearishTYK Medicines
01 Mar 2024 08:55

Pre-IPO TYK Medicines - Survival Risk Is Imminent, with Limited Highlights in the Pipeline

Except TY-9591 for brain metastases from NSCLC, the rest pipeline has little highlight but with fierce competition.As a biotech with no...

Logo
515 Views
Share
31 Jul 2023 08:55

Interpretation of the New Adjustments in Medical Insurance (NRDL) Negotiation Rules and the Impact

It's necessary to explain the NRDL negotiation system and new adjustments, which increase the predictability of drug price decline.Investors are...

Logo
204 Views
Share
27 May 2023 00:39

No Traction Above $93 on ACWI-US or 4400-4415 on EURO STOXX 50. Buys in Defensives/Japan/EM

No Traction Above $93 on MSCI $ACWI or 4400-4415 on EURO #STOXX 50. Continues to reinforce our view from early-January that $93 on ACWI caps upside...

Logo
41 Views
Share
23 May 2023 00:16

EM Strategy: MSCI EM Financials & Energy Improving-Overweight; Overweights: Taiwan, India, Mexico

MSCI EM Financials & Energy Improving -- Upgrading to Overweight; MSCI EM Technology remains an Overweight. Top Country Overweights: Taiwan, India,...

Logo
200 Views
Share
13 Feb 2023 08:55

Jacobio Pharmaceuticals Placement (1167.HK) - We Keep Hope for Jacobio Because of Dr. Wang Yinxiang

Jacobio's situation and prospects are full of challenges, but Dr. Wang Yinxiang/Jacobio is among the few biotech under Chapter 18A who really...

Logo
317 Views
Share
x